These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29129776)

  • 1. Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review.
    Koshal P; Jamwal S; Kumar P
    Neuropharmacology; 2018 Jul; 136(Pt B):271-279. PubMed ID: 29129776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities.
    Manavi MA
    Neuropeptides; 2022 Aug; 94():102250. PubMed ID: 35561568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides.
    Vrang N; Larsen PJ
    Prog Neurobiol; 2010 Nov; 92(3):442-62. PubMed ID: 20638440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice.
    Koshal P; Kumar P
    Mol Cell Biochem; 2016 Apr; 415(1-2):77-87. PubMed ID: 26965494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the role of neurotransmitters in epilepsy: An updated review.
    Akyuz E; Polat AK; Eroglu E; Kullu I; Angelopoulou E; Paudel YN
    Life Sci; 2021 Jan; 265():118826. PubMed ID: 33259863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of GABAA Receptors in the Treatment of Epilepsy.
    Palma E; Ruffolo G; Cifelli P; Roseti C; Vliet EAV; Aronica E
    Curr Pharm Des; 2017; 23(37):5563-5568. PubMed ID: 28799512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence.
    Jerlhag E
    Neuropharmacology; 2018 Jul; 136(Pt B):343-349. PubMed ID: 29337226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving targets for anti-epileptic drug discovery.
    Raut D; Bhatt LK
    Eur J Pharmacol; 2020 Nov; 887():173582. PubMed ID: 32950499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: How to improve the antiepileptic effect?
    Werner FM; Coveñas R
    Epilepsy Behav; 2017 Jun; 71(Pt B):124-129. PubMed ID: 25819950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
    Bassil F; Fernagut PO; Bezard E; Meissner WG
    Prog Neurobiol; 2014 Jul; 118():1-18. PubMed ID: 24582776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic developmental rules and their implications for epilepsy in the immature brain.
    Ben-Ari Y
    Epileptic Disord; 2006 Jun; 8(2):91-102. PubMed ID: 16793570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in hypothalamic neurotransmitter and prostanoid levels in response to NMDA, CRF, and GLP-1 stimulation.
    Kondo F; Tachi M; Gosho M; Fukayama M; Yoshikawa K; Okada S
    Anal Bioanal Chem; 2015 Jul; 407(18):5261-72. PubMed ID: 25633219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptides: A promising target for treating seizures.
    Menon N; Prabhavalkar KS; Bhatt LK
    Neuropeptides; 2017 Oct; 65():63-70. PubMed ID: 28559061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs.
    Werner FM; Coveñas R
    Curr Med Chem; 2011; 18(32):4933-48. PubMed ID: 22050744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.
    Hadera MG; McDonald T; Smeland OB; Meisingset TW; Eloqayli H; Jaradat S; Borges K; Sonnewald U
    Neurochem Res; 2016 Feb; 41(1-2):86-95. PubMed ID: 26433381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line.
    Gameiro A; Reimann F; Habib AM; O'Malley D; Williams L; Simpson AK; Gribble FM
    J Physiol; 2005 Dec; 569(Pt 3):761-72. PubMed ID: 16223757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of spinal GLP-1 receptor signaling.
    Zhang D; Lv G
    Peptides; 2018 Mar; 101():89-94. PubMed ID: 29329976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Study of the Mechanism of Action of the Potential Anti-Epileptic Agent Q808.
    Li X; Zhang HJ; Wang Q; Zhang DW; Wu D; Li W; Quan ZS
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28686214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
    Vrang N; Larsen PJ; Jensen PB; Lykkegaard K; Artmann A; Larsen LK; Tang-Christensen M
    Brain Res; 2008 Jan; 1187():116-24. PubMed ID: 18022140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
    Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
    Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.